As of January 18, 2016, NASDAQ OMX Derivatives Markets will introduce standardised derivatives on Frontline (FRO), Genmab (GEN) and Swedish Orphan Biovitrum (SOBI).
Derivatives on Frontline, Genmab and Swedish Orphan Biovitrum will have a term of 3 months. In Nasdaq’s derivative trading and clearing systems, the ticker symbols will be FRO, GEN and SOBI.
Ticker Symbol Underlying Code Risk Parameter Sector
Frontline FRO 13184 32% Industrial Goods &
Services
Genmab GEN 13185 20% Health Care
Swedish Orphan Biovitrum SOBI 3669 25% Health Care
As of January 11, 2016, the new series will be available in Genium INET, but not tradable until January 18, 2016. The series will be included in the Market Notice “New Strikes Stock Products” that will be sent out after business on January 8, 2016.
Susquehanna will be quoting prices for derivatives on Frontline, Genmab and Swedish Orphan Biovitrum.
For further information concerning this exchange notice please see the attached file or contact Mikael Siewertz, telephone +46 8 405 66 34
